Skip to Content
Merck
  • Photodegradation and stabilization of betamethasone-17 valerate in aqueous/organic solvents and topical formulations.

Photodegradation and stabilization of betamethasone-17 valerate in aqueous/organic solvents and topical formulations.

AAPS PharmSciTech (2012-12-20)
Saif-ur-Rehman Khattak, Dilnawaz Shaikh, Iqbal Ahmad, Khan Usmanghani, Muhammad Ali Sheraz, Sofia Ahmed
ABSTRACT

The effects of solvent [acetonitrile, methanol, and acetonitrile/water mixture (20:80, v/v)], buffer concentration (phosphate buffer, pH 7.5), ionic strength and commonly employed adjuvants on the photodegradation of betamethasone-17 valerate in cream and gel formulations have been studied on exposure to UV light (300-400 nm). A validated high-performance liquid chromatography method has been used to determine the parent compound and its photodegraded products. The photodegradation data in the studied solvents showed greater decomposition of the drug in solvents with a lower dielectric constant. A comparatively higher rate of photodegradation was observed in the cream formulation compared to that for the gel formulation. The kinetic treatment of the photodegradation data revealed that the degradation of the drug follows first-order kinetics and the apparent first-order rate constants for the photodegradation reactions, in the media studied, range from 1.62 to 11.30×10(-3) min(-1). The values of the rate constants decrease with increasing phosphate concentration and ionic strength which could be due to the deactivation of the excited state and radical quenching. The second-order rate constant (k') for the phosphate ion-inhibited reactions at pH 7.5 has been found to be 5.22×10(-2) M(-1) s(-1). An effective photostabilization of the drug has been achieved in cream and gel formulations with titanium dioxide (33.5-42.5%), vanillin (21.6-28.7%), and butyl hydroxytoluene (18.2-21.6%).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Betamethasone 17-valerate
Supelco
Betamethasone 17-valerate, VETRANAL®, analytical standard
Betamethasone 17-valerate, European Pharmacopoeia (EP) Reference Standard
Betamethasone valerate for system suitability, European Pharmacopoeia (EP) Reference Standard